John David Finley - 04 Sep 2025 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role: CEO, CFO, Director
Signature: /s/ Ryker Willie, Attorney-in-Fact
Issuer symbol: PALI
Transactions as of: 04 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Sep 2025, 09:00:39 UTC
Previous filing: 13 Feb 2025
Next filing: 08 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Finley John David	CEO, CFO, Director	1902 WRIGHT PLACE, SUITE 200, CARLSBAD,	/s/ Ryker Willie, Attorney-in-Fact	05 Sep 2025	0001851034

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Phantom Units	Award	$0	+323,400		$0.000000	323,400	04 Sep 2025	Common Stock	323,400		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.
F2	The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.
F3	Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan.